1 Min Read
April 9 (Reuters) - Dermapharm Holding SE:
* REVENUE IN 2017 UP 4.9% FROM LAST YEAR TO EUR 467 MILLION
* FY ADJUSTED EBITDA UP 9.7% FROM LAST YEAR TO EUR 113 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.